Skip to main content
Caplight Logo









MedSimples

MedSimples

Private
São PauloHealthcare & Life Scienceshttps://www.medsimples.com.br/

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MedSimples operates in Healthcare & Life Sciences and is based in São Paulo. It was founded in 2018.

MedSimples is a healthtech company that provides a digital platform for healthcare institutions to automate administrative processes, manage medical shifts, and facilitate financial payments for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Revenue Cycle, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MedSimples Comparables

Compare MedSimples with similar companies based on industry and business-model similarity.

MedSimples comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fin-X
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MedSimples Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for MedSimples. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Guilherme Machado de Figueiredo Murari

Chief Technology Officer - Diretor de Tecnologia

Executive Team

Murilo Castro

Sócio, Chief Operating Officer (COO)

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 160% MoM, reaching 25.4K.

  • Aug 19, 2026

    Grew 34% QoQ, from 35 to 47 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

MedSimples Filings

Explore SEC and related filing metadata, where available.

MedSimples filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MedSimples's valuation, stock price, and market status.

Is MedSimples a public or private company?

MedSimples is a private company.

What is the current stock price of MedSimples?

MedSimples is a private company, so its shares have no public market price. Caplight tracks MedSimples's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MedSimples worth (valuation)?

Valuation information for MedSimples is not publicly available.

Can I buy MedSimples stock?

MedSimples shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MedSimples's last funding round?

Funding round information for MedSimples is not publicly available.

Who are the main investors in MedSimples?

Investor information for MedSimples is not publicly disclosed.

Will MedSimples IPO soon?

No public IPO plans have been announced for MedSimples.

How can I track MedSimples secondary market activity?

Caplight tracks bids, offers, and trades in MedSimples's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range39
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?